ArticleSpinal cord2026

Nanoformulated fingolimod for spinal cord injury: promising anti‑neuroinflammatory effects but unsubstantiated bioavailability claims.

Rizaev Jasur et al.PubMed ↗Publisher ↗

No numbers read from the abstract.